Tenaya Therapeutics Inc. (NASDAQ: TNYA) announced it will report interim data from its MyPEAK-1 Phase 1b/2 trial of TN-201 gene ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE